Quantcast
Environmental News for a Healthier Planet and Life

Help Support EcoWatch

FDA Likely to Approve Remdesivir to Treat COVID-19

Health + Wellness
A vial of the drug remdesivir at a press conference at the University Hospital Eppendorf in Hamburg, Germany on April 8, 2020, during the new coronavirus COVID-19 pandemic. ULRICH PERREY / POOL / AFP via Getty Images

Even though the death toll from COVID-19 in the U.S. topped 60,000 on Wednesday, there was a glimmer of good news as a small trial for the drug remdesivir showed promise in helping patients recover faster, as The Washington Post reported.


The Food and Drug Administration is likely to announce an emergency approval for remdesivir, a senior administration official told The New York Times. Another drug touted by the president, hydrochloroquine, also was granted an emergency approval, but results in patients have been disappointing and the side effects for people with heart conditions may be fatal.

The FDA said it is in talks with Gilead Sciences, the maker of remdesivir, about making the drug available to patients, according to statement provided to CNN.

"As part of the FDA's commitment to expediting the development and availability of potential COVID-19 treatments, the agency has been engaged in ... discussions with Gilead Sciences regarding making remdesivir available to patients as quickly as possible, as appropriate," FDA spokesman Michael Felberbaum said in a statement, as CNN reported.

The study showed that patients treated with remdesivir were able to leave the hospital within 11 days, on average, compared with an average of 15 days for patients who had received a placebo. The trial, which was sponsored by the National Institute of Allergy and Infectious Diseases, enrolled 1,063 patients. It gave the patients either the drug or a placebo, as The New York Times reported.

There were also fewer deaths in the remedisvir group, but it was a large enough discrepancy to be statistically significant.

"The data shows that remdesivir has a clear-cut, significant, positive effect in diminishing the time to recovery," said Dr. Anthony S. Fauci, the National Institute of Allergy and Infectious Diseases, at the White House on Wednesday, as The Washington Post reported. "That is really quite important."

Fauci admitted that the drug is not a cure, but it opens an important and promising avenue for future study. "Although a 31 percent improvement doesn't seem like a knockout 100 percent, it is very important proof of concept," Fauci said of remdesivir, as CNN reported. "What it has proven is that a drug can block this virus."

The effect that remidisvir has is similar to what Tamilflu does to the flu. It doesn't cure the flu – it just helps reduce how long people are sick, according to CNN.

Fauci did warn that the results still need proper peer-review, but he was optimistic that remdesivir would become "the standard of care" for patients with Covid-19, according to The New York Times.

It's highly unusual for data about a drug's efficacy to be released this early from a preliminary trial. But "whenever you have clear-cut evidence that a drug works, you have an ethical obligation to immediately let the people in the placebo group know so that they can have access," Fauci said, as CNN reported.

That didn't pass muster with many in the medical and scientific community. The disclosure of trial results in a political setting, before peer review or publication, is very unusual, said Dr. Steven Nissen, a cardiologist at the Cleveland Clinic who has conducted dozens of clinical trials, to The New York Times.

"Where are the data?" he asked. "This is too important to be handled in such a sloppy fashion," Nissen said.

Dr. Michele Barry, a global health expert at Stanford University who expressed confidence in Fauci, told The New York Times, "It is unusual to call a drug the 'standard of care' until peer review of data and publication, and before studies have shown benefit in mortality."

EcoWatch Daily Newsletter

Malte Mueller / Getty Images

By David Korten

Our present course puts humans on track to be among the species that expire in Earth's ongoing sixth mass extinction. In my conversations with thoughtful people, I am finding increasing acceptance of this horrific premise.

Read More Show Less
Women sort potatoes in the Andes Mountains near Cusco Peru on July 7, 2014. Thomas O'Neill / NurPhoto / Getty Images

By Alejandro Argumedo

August 9 is the International Day of the World's Indigenous Peoples – a celebration of the uniqueness of the traditions of Quechua, Huli, Zapotec, and thousands of other cultures, but also of the universality of potatoes, bananas, beans, and the rest of the foods that nourish the world. These crops did not arise out of thin air. They were domesticated over thousands of years, and continue to be nurtured, by Indigenous people. On this day we give thanks to these cultures for the diversity of our food.

Read More Show Less
A sand tiger shark swims over the USS Tarpon in Monitor National Marine Sanctuary. Tane Casserley / NOAA

By John R. Platt

Here at The Revelator, we love a good shark story.

The problem is, there aren't all that many good shark stories. According to recent research, sharks and their relatives represent one of the world's most imperiled groups of species. Of the more than 1,250 known species of sharks, skates, rays and chimeras — collectively known as chondrichthyan fishes — at least a quarter are threatened with extinction.

Read More Show Less
The Anderson Community Group. Left to right, Caroline Laur, Anita Foust, the Rev. Bryon Shoffner, and Bill Compton, came together to fight for environmental justice in their community. Anderson Community Group

By Isabella Garcia

On Thanksgiving Day 2019, right after Caroline Laur had finished giving thanks for her home, a neighbor at church told her that a company had submitted permit requests to build an asphalt plant in their community. The plans indicated the plant would be 250 feet from Laur's backdoor.

Read More Show Less
Berber woman cooks traditional flatbread using an earthen oven in her mud-walled village home located near the historic village of Ait Benhaddou in Morocco, Africa on Jan. 4, 2016. Creative Touch Imaging Ltd. /NurPhoto / Getty Images

By Danielle Nierenberg and Jason Flatt

The world's Indigenous Peoples face severe and disproportionate rates of food insecurity. While Indigenous Peoples comprise 5 percent of the world's population, they account for 15 percent of the world's poor, according to the World Health Organization.

Read More Show Less
Danny Choo / CC BY-SA 2.0

By Olivia Sullivan

One of the many unfortunate outcomes of the coronavirus pandemic has been the quick and obvious increase in single-use plastic products. After COVID-19 arrived in the United States, many grocery stores prohibited customers from using reusable bags, coffee shops banned reusable mugs, and takeout food with plastic forks and knives became the new normal.

Read More Show Less

Trending

A mostly empty 110 freeway toward downtown Los Angeles, California on April 28, 2020. Robert Gauthier / Los Angeles Times via Getty Images

The shelter in place orders that brought clean skies to some of the world's most polluted cities and saw greenhouse gas emissions plummet were just a temporary relief that provided an illusory benefit to the long-term consequences of the climate crisis. According to new research, the COVID-19 lockdowns will have a "neglible" impact on global warming, as Newshub in New Zealand reported.

Read More Show Less